AEP
61
-3
VZ
35
-2
CFG
95
2
FIS
58
2
TXT
82
4
APD
45
-2
LOW
43
-6
NFLX
40
3
STZ
42
-2
CAG
41
-5
CTAS
40
-2
T
23
2
MTB
73
4
RIG
40
2
DRI
66
2
MA
55
4
LMT
59
4
EMC
47
11
PNW
53
-3
EQIX
64
5
AEP
61
-3
VZ
35
-2
CFG
95
2
FIS
58
2
TXT
82
4
APD
45
-2
LOW
43
-6
NFLX
40
3
STZ
42
-2
CAG
41
-5
CTAS
40
-2
T
23
2
MTB
73
4
RIG
40
2
DRI
66
2
MA
55
4
LMT
59
4
EMC
47
11
PNW
53
-3
EQIX
64
5
Financhill
Back

Vanguard Tax-Exempt Bond Index Fund ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
49

VTEB
Vanguard Tax-Exempt Bond Index Fund ETF

Last Price:
$50.15
Seasonality Move:
-1.64%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$55.85
Seasonality Move:
14.46%
Sell
49
Vanguard Tax-Exempt Bond Index Fund ETF (VTEB) is a Sell

Is Vanguard Tax-Exempt Bond Index Fund ETF a Buy, Sell or Hold?

  • The current Vanguard Tax-Exempt Bond Index Fund ETF [VTEB] share price is $50.17. The Score for VTEB is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • VTEB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VTEB Stock Price Chart

What is Vanguard Tax-Exempt Bond Index Fund ETF's stock price today?

  • The Vanguard Tax-Exempt Bond Index Fund ETF share price today is $50.17
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTEB is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $55.86
    The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.

VTEB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.44 Buy
Relative Strength Index (14 RSI): 42.31 Sell
Chaikin Money Flow: 5626226 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.2 - 50.4) Sell
Bollinger Bands (100): (49.26 - 50.52) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 49.16 Sell
Chaikin Money Flow: 78181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.94 - 57.06) Buy
Bollinger Bands (100): (52.44 - 65.4) Sell

VTEB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.23 Sell
20-day SMA: 50.28 Sell
50-day SMA: 50.37 Sell
200-day SMA: 49.44 Buy
8-day EMA: 26.58 Buy
20-day EMA: 13.02 Buy
50-day EMA: 5.68 Buy
200-day EMA: 1.48 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.25 Sell
20-day SMA: 55.05 Buy
50-day SMA: 58.96 Sell
200-day SMA: 51.1 Buy
8-day EMA: 55.79 Buy
20-day EMA: 55.79 Buy
50-day EMA: 56.36 Sell
200-day EMA: 37.56 Buy

Vanguard Tax-Exempt Bond Index Fund ETF Earnings Growth & VTEB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

Vanguard Tax-Exempt Bond Index Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):